Cat.#: ACPP-1331
| Despition | GPR56 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1269 | Mouse GDNF Protein (AC1269) | 2 µg | inquiry |
| ACPP-1377 | Human KCNMB3 Protein (AC1377) | 5 µg | inquiry |
| ACPP-1661 | Human HEXA Protein, Sf9 (AC1661) | 2 µg | inquiry |
| ACPP-1844 | Human GCLM Protein (AC1844) | 5 µg | inquiry |
| ACPP-1209 | CaMKII gamma Blocking Peptide (AC1209) | 250 µg | inquiry |
| ACPP-1807 | Human QKI Protein (AC1807) | 2 µg | inquiry |
| ACPP-1793 | Human HSPB8 Protein, His (AC1793) | 2 µg | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
| ACPP-1691 | Human MGLL Protein (AC1691) | 2 µg | inquiry |
| ACPP-1182 | Recombinant Cynomolgus macaque Midkine Protein (Fc Tag) (AC1182) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.